CENPV: A Promising Drug Target for Cellular Processes (G201161)

Target Name: CENPV

NCBI ID: G201161

CENPV

CENPV: A Promising Drug Target for Cellular Processes

CENPV (Nuclear Protein p30) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key regulator of the cell cycle and has been implicated in a number of cellular processes, including the regulation of cell growth, apoptosis, and inflammation.

One of the things that makes CENPV an attractive drug target is its role in the regulation of cell cycle progression. CENPV has been shown to play a key role in the metaphase of the cell cycle, which is the stage at which a cell enters its replication phase. During this stage, CENPV helps to ensure that the cell enters the replication phase at the right time and that the replication process is properly regulated.

Another way that CENPV has been shown to be a potential drug target is its role in the regulation of apoptosis, which is the process by which a cell undergoes its programmed cell death. CENPV has been shown to play a key role in the regulation of apoptosis, by helping to ensure that cells are properly programmed to die when they are no longer needed.

In addition to its role in the regulation of cell cycle progression and apoptosis, CENPV has also been shown to be involved in the regulation of inflammation. It has been shown to play a key role in the regulation of the immune response, by helping to ensure that cells are properly regulated in response to the presence of foreign substances in the body.

Despite these promising findings, much more research is needed before CENPV can be fully understood as a drug target. For example, it is not yet clear exactly how CENPV functions as a drug target, or what the best way to target it would be. Additionally, there are concerns that CENPV may be involved in a number of other cellular processes that could make it an attractive drug target, such as the regulation of cell signaling pathways, the development of cancer, and the aging process.

In conclusion, CENPV is a protein that has the potential to be a drug target due to its role in the regulation of cell cycle progression, apoptosis, and inflammation. Further research is needed to fully understand its function as a drug target and to determine the best way to target it.

Protein Name: Centromere Protein V

Functions: Required for distribution of pericentromeric heterochromatin in interphase nuclei and for centromere formation and organization, chromosome alignment and cytokinesis

The "CENPV Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CENPV comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets